Most people have heard of the placebo effect, the curious phenomenon whereby a dummy pill can leave patients feeling better. Far less familiar is its shadowy twin. The word nocebo comes from the Latin for 'I shall harm', and it describes what happens when negative expectations make people feel worse – sometimes in ways that are surprisingly real.
The clearest evidence comes from clinical trials. In a well-designed trial, some volunteers receive the medicine being tested while others receive an inert substitute, and neither group knows which they have been given. Strikingly, a noticeable share of those taking the dummy pill report side effects: headaches, tiredness, an upset stomach. What is more, the complaints they describe often mirror those listed on the information sheet they read before the trial began. Having been told what to look out for, they seem to find it.
Not that these people are imagining things. Researchers stress that nocebo symptoms are genuinely experienced. Anxiety can heighten the body's stress response, and a person who is watching nervously for trouble is more likely to notice the ordinary aches and twinges that everyone has from time to time – and to attribute them to the treatment. Brain-imaging studies suggest that expecting pain can even change how strongly pain signals are processed. In other words, the effect is less a trick of the imagination than a demonstration of how closely mind and body are intertwined.
This poses an awkward problem for doctors. Patients have a right to know about the possible risks of a treatment; informed consent is a cornerstone of modern medical ethics. Yet if describing risks can itself make people feel worse, how should information be shared? Few experts would argue for withholding the truth. Instead, many recommend paying closer attention to framing. Explaining that most people take a medicine without any problems, while a small number notice mild headaches, is just as truthful as reciting a long list of possible reactions, but it is likely to leave a patient feeling far less alarmed.
Dr Helen Marsh, who studies communication between doctors and patients at a university in Bristol, puts it this way: 'Honesty and reassurance are not opposites. The words we choose can either feed anxiety or ease it, and choosing them well is a clinical skill in its own right.'
The nocebo effect may also help to explain some everyday experiences. Reading alarming stories online about a medicine, or hearing a friend's account of a bad reaction, can shape what a person expects before they have swallowed a single tablet. Even packaging can play a part: some studies have found that people report more unwanted effects from a generic version of a medicine than from a familiar brand, despite the two being chemically identical.
None of this means that every side effect is 'all in the mind'. Medicines can and do cause real harm, and dismissing a patient's symptoms would be both unkind and dangerous. Anyone who feels unwell after starting a treatment should talk to a doctor rather than simply stopping it on their own. What the research does suggest is that expectations are a powerful ingredient in any treatment. Only by recognising this, scientists argue, can medicine make full use of words, trust and reassurance – tools that cost nothing and may spare patients a great deal of unnecessary suffering.